Sign inJoin waitlistJoin the waitlist

Omar Alhalabi

Team Leader · University of Texas M D Anderson Cancer Center

Credentials: · · · · · ·

History

University of Texas M D Anderson Cancer Center
Present

The University of Texas MD Anderson Cancer
2017–2020
Internal Medicine
Corewell Health William Beaumont University Hospital
2014–2017
Case Western Reserve University
2013–2014
Doctor of Medicine
2009–2013

Research

Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
Nature Medicine · 2020 · 269 citations
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Nature Communications · 2021 · 194 citations
Factor XII and uPAR upregulate neutrophil functions to influence wound healing
Journal of Clinical Investigation · 2018 · 125 citations

Matthew Campbell
37 papers
Jianjun Gao
30 papers
Amishi Shah
29 papers
Pavlos Msaouel
26 papers · 17 as a resident
Arlene Siefker-Radtke
20 papers
Ashish Kamat
19 papers
Nizar Tannir
19 papers
Charles Guo
17 papers
Petros Grivas
11 papers
Sangeeta Goswami
11 papers
Andrew Hahn
10 papers · 6 as a fellow
Cindy Jiang
10 papers · 10 as a fellow

Clinical trials

A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2023–2027